RT @alongi_filippo: @piet_ost @DrAndrewLoblaw @SbrtSean @AmarUKishan @alison_tree Here some details of our approach and toxicity https://t.…
@piet_ost @DrAndrewLoblaw @SbrtSean @AmarUKishan @alison_tree Here some details of our approach and toxicity https://t.co/7ifzH488Kf
RT @alongi_filippo: @SbrtSean SBRT similar(well tolerated also in our series) as moderate fractionation. https://t.co/7ifzH488Kf
RT @alongi_filippo: @SbrtSean SBRT similar(well tolerated also in our series) as moderate fractionation. https://t.co/7ifzH488Kf
@SbrtSean SBRT similar(well tolerated also in our series) as moderate fractionation. https://t.co/7ifzH488Kf
RT @radoncpapers: Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low- and favorable intermediate…
Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low- and favorable intermediate-risk prostate cancer patients. https://t.co/59ZmvjplWn H/T @NCBI #radonc #PubMed